Boulder Diagnostics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $7.9M

Boulder Diagnostics General Information

Description

Developer of immunology-based assays designed to treat rheumatology and infectious diseases. The company is primarily engaged in developing diagnostic reagents and tests for infectious diseases and other protein targets.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 6395 Gunpark Drive
  • Suite W
  • Boulder, CO 80301
  • United States
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 6395 Gunpark Drive
  • Suite W
  • Boulder, CO 80301
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Boulder Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 31-Jul-2014 $7.9M Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Boulder Diagnostics’s complete valuation and funding history, request access »

Boulder Diagnostics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Reich Web Consulting Corporation Minority
Ventac Partners Venture Capital Minority
To view Boulder Diagnostics’s complete investors history, request access »

Boulder Diagnostics FAQs

  • When was Boulder Diagnostics founded?

    Boulder Diagnostics was founded in 2009.

  • Where is Boulder Diagnostics headquartered?

    Boulder Diagnostics is headquartered in Boulder, CO.

  • What industry is Boulder Diagnostics in?

    Boulder Diagnostics’s primary industry is Biotechnology.

  • Is Boulder Diagnostics a private or public company?

    Boulder Diagnostics is a Private company.

  • What is the current valuation of Boulder Diagnostics?

    The current valuation of Boulder Diagnostics is .

  • What is Boulder Diagnostics’s current revenue?

    The current revenue for Boulder Diagnostics is .

  • Who are Boulder Diagnostics’s investors?

    Reich Web Consulting and Ventac Partners have invested in Boulder Diagnostics.

  • When was Boulder Diagnostics acquired?

    Boulder Diagnostics was acquired on 31-Jul-2014.

  • Who acquired Boulder Diagnostics?

    Boulder Diagnostics was acquired by Oxford Immunotec.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »